Literature DB >> 16377713

Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea.

Jae Il Yoo1, Eun Shim Shin, Jeong Ok Cha, Jeom Kyu Lee, Young Hee Jung, Kyeong Min Lee, Bong Su Kim, Yeong Seon Lee.   

Abstract

We identified 25 high-level mupirocin-resistant (MuH) and 21 low-level mupirocin-resistant (MuL) Staphylococcus aureus isolates from eight long-term-care facilities (LTCFs). The pulsed-field gel electrophoresis patterns of 19 MuH and 19 MuL isolates from two facilities were identical for 18 and 15 isolates, respectively. The most predominant mupA restriction fragment length polymorphism type was found in 21 MuH isolates. We conclude that clonal transmission of MuH and MuL S. aureus strains occurred in these LTCFs. This is the first report of clonal transfer of mupirocin resistance in LTCFs.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16377713      PMCID： PMC1346793          DOI： 10.1128/AAC.50.1.365-367.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Prevalence of mupirocin resistance in Staphylococcus aureus.

Authors:  R R Marples; D C Speller; B D Cookson
Journal:  J Hosp Infect       Date:  1995-02       Impact factor: 3.926

2.  Control of MRSA in a long-term care facility.

Authors:  A E Simor; A Augustin; J Ng; S Betschel; M McArthur
Journal:  Infect Control Hosp Epidemiol       Date:  1994-02       Impact factor: 3.254

3.  Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia.

Authors:  T V Riley; C F Carson; R A Bowman; L Mulgrave; C L Golledge; J W Pearman; W B Grubb
Journal:  Med J Aust       Date:  1994-09-19       Impact factor: 7.738

4.  Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.

Authors:  M A Miller; A Dascal; J Portnoy; J Mendelson
Journal:  Infect Control Hosp Epidemiol       Date:  1996-12       Impact factor: 3.254

5.  Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates.

Authors:  M A Ramsey; S F Bradley; C A Kauffman; T M Morton
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital.

Authors:  M C Layton; J E Patterson
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.

Authors:  C A Kauffman; M S Terpenning; X He; L T Zarins; M A Ramsey; K A Jorgensen; W S Sottile; S F Bradley
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

8.  Colonization and infection with antibiotic-resistant bacteria in a long-term care facility.

Authors:  M S Terpenning; S F Bradley; J Y Wan; C E Chenoweth; K A Jorgensen; C A Kauffman
Journal:  J Am Geriatr Soc       Date:  1994-10       Impact factor: 5.562

9.  Characterization of a conjugative staphylococcal mupirocin resistance plasmid.

Authors:  T M Morton; J L Johnston; J Patterson; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  Mupirocin resistance in coagulase-negative staphylococci.

Authors:  S Connolly; W C Noble; I Phillips
Journal:  J Med Microbiol       Date:  1993-12       Impact factor: 2.472
View more
  5 in total

1.  Amplification of the gene for isoleucyl-tRNA synthetase facilitates adaptation to the fitness cost of mupirocin resistance in Salmonella enterica.

Authors:  Wilhelm Paulander; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Genetics       Date:  2010-02-22       Impact factor: 4.562

2.  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.

Authors:  Andrew E Simor; Tammy L Stuart; Lisa Louie; Christine Watt; Marianne Ofner-Agostini; Denise Gravel; Michael Mulvey; Mark Loeb; Allison McGeer; Elizabeth Bryce; Anne Matlow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

3.  Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center.

Authors:  Tara Babu; Violeta Rekasius; Jorge P Parada; Paul Schreckenberger; Malliswari Challapalli
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

4.  The Prevalence, Genotype and Antimicrobial Susceptibility of High- and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus.

Authors:  Se Young Park; Shin Moo Kim; Seok Don Park
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

5.  In Vitro Antimicrobial Activities of Fusidic Acid and Retapamulin against Mupirocin- and Methicillin-Resistant Staphylococcus aureus.

Authors:  Sang Hyun Park; Jin Kyung Kim; Kun Park
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.